State DC
Clinical Trials in Washington D.C.
Recruiting clinical trials with at least one study location in Washington D.C.. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington D.C.
Breast Cancer (6)Head and Neck Squamous Cell Carcinoma (3)Esophageal Cancer (3)Prostate Cancer (3)Prostate Adenocarcinoma (3)Chronic Inflammatory Demyelinating Polyneuropathy (2)Bladder Cancer (2)Multiple Sclerosis (2)Stage IV Lung Cancer AJCC v8 (2)High Grade Glioma (2)Diffuse Intrinsic Pontine Glioma (2)Asthma (2)
Frequently Asked Questions — Clinical Trials in Washington D.C.
How many clinical trials are currently recruiting in Washington D.C.?
ClinicalMetric currently tracks 145 actively recruiting clinical trials with at least one location in Washington D.C.. The total number of registered studies—including active but not currently enrolling trials—is 145. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Washington D.C.?
Washington D.C. hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Head and Neck Squamous Cell Carcinoma, Esophageal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Washington D.C. serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Washington D.C.?
To join a clinical trial in Washington D.C., browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Washington D.C. maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Washington D.C.
NCT06858579 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic In...
Condition
Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
256 pts
Location
United States, Argentina, Australia
Sponsor
Dianthus Therapeutics
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung...
Condition
Patients With Non-Small Cell Lung Cancer
Enrollment
363 pts
Location
United States, Belgium, Canada
Sponsor
OSE Immunotherapeutics
NCT06162221 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Condition
Non-Small Cell Lung Cancer, NSCLC
Enrollment
616 pts
Location
United States, Australia, Denmark
Sponsor
Revolution Medicines, Inc.
NCT04899947 N/A
Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
Condition
Narcolepsy
Enrollment
500 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
NCT06872307 N/A
Recruiting
Intervention to Enhance PrEP Persistence
Condition
HIV Prevention
Enrollment
300 pts
Location
United States
Sponsor
Brown University
NCT05656235 Phase 2
Recruiting
Renal Retention in High Grade Upper Tract Urothelial Cancer
Condition
High Grade Urothelial Carcinoma
Enrollment
20 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca
NCT06433752 N/A
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMV...
Condition
Relapsing Multiple Sclerosis
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
TG Therapeutics, Inc.
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04655404 EARLY_Phase 1
Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK F...
Condition
High Grade Glioma
Enrollment
15 pts
Location
United States, Australia, Canada
Sponsor
Nationwide Children's Hospital
NCT06796543 N/A
Recruiting
Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With So...
Condition
Metastatic Sarcoma
Enrollment
70 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT05533697 Phase 1, Phase 2
Recruiting
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint ...
Condition
Advanced Solid Tumors
Enrollment
361 pts
Location
United States, Australia, Spain
Sponsor
ModernaTX, Inc.
NCT05692180 Phase 3
Recruiting
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Tim...
Condition
Asthma
Enrollment
200 pts
Location
United States, Argentina, Canada
Sponsor
AstraZeneca
NCT03794362 N/A
Recruiting
Measuring Analgesic Interventions
Condition
Pain
Enrollment
120 pts
Location
United States
Sponsor
Julia Finkel
NCT06429982 Phase 1
Recruiting
Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard P...
Condition
Rhabdomyolysis
Enrollment
50 pts
Location
United States
Sponsor
Children's National Research I
NCT06944522 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Ha...
Condition
Parkinsons Disease (PD)
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
BlueRock Therapeutics
NCT05647122 Phase 1
Recruiting
First in Human Study of AZD9592 in Solid Tumors
Condition
Advanced Solid Tumours
Enrollment
403 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT06290869 Phase 3
Recruiting
Tobacco Education and Lung Health Study (TEAL)
Condition
Smoking Cessation
Enrollment
1,188 pts
Location
United States
Sponsor
Georgetown University
NCT04879329 Phase 2
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer Th...
Condition
Urothelial Carcinoma
Enrollment
372 pts
Location
United States, Argentina, Australia
Sponsor
Seagen, a wholly owned subsidi
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05896839 Phase 1, Phase 2
Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
16 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06894979 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy f...
Condition
Childhood Astrocytoma
Enrollment
54 pts
Location
United States
Sponsor
Children's Oncology Group
Page 1 of 6 — 145 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology